Mangaluru: Activist Vidya Dinker bags Lawrence Pinto Human Rights Award

Kasaragod, Apr 17: Even as this district continue to remain in the high-alert red zone category of Covid-19, Kasaragod has slowly but steadily been limping back to restraint level of the pandemic from a possible slipping into a stage-3 of community spread early this month.

Thanks to the stringent and committed measures implemented by the district administration crisscross the district besides total isolation of few localities by enforcing triple lockdown.

The district had been a Covid-19 hotspot ever since an NRI who returned from the Gulf violated quarantine protocol and travelled wide and far by meeting and contacting with several people including two MLAs of the district. That apart the irresponsible attitude of the people who broke the rules of quarantine and lockdown norms also made things go from bad to worse resulting in contributing for a near-half of the total positive cases in the state at the beginning of April.

Mangaluru, May 23: Criticising the Karnataka government's fresh protocol for management of Covid-19 as expensive, a prominent physician in the city has demanded its withdrawal.

According to Dr B Srinivas Kakkilaya, the protocol released by the Health and Family Welfare Department on May 15 enlists unnecessary and unconfirmed tests and treatments. 

The protocol has classified Covid-19 cases into three categories and has provided for hospitalisation of all three categories of patients, from asymptomatic to the most severely ill.

In a letter to the government, Dr Kakkilaya said: "The protocol suggests several investigations to be done right on the day of admission, including blood counts, liver and renal function tests, chest X Ray, ECG, CT scan of the chest, and other special investigations, all of which, if done, will cost Rs 25,000 per patient."

"In the coming days when lakhs of patients are likely to be infected with SARS CoV2, is it necessary and feasible to hospitalise and test all these patients at Rs 25,000 per person," he questioned.

The treatment options suggested in the protocol are also surprising, he pointed out. "The protocol recommends choloroquine, azithromycin, oseltamivir, zinc and vitamin C for all patients, from asymptomatic to the severely ill, and also anti coagulant injections for many patients. All these would cost at least Rs 5,000 per patient. For severe cases of Covid-19, many unproven and experimental treatments have been suggested, which are very expensive and highly questionable," Dr Kakkilaya notes.

Therefore, this protocol, he asserted was not evidence based and likely to do more harm than good. He said these unnecessarily expensive tests and allowing private companies to conduct trials on Covid-19 patients is likely to be misused by vested interests and must be immediately withdrawn, and instead, a protocol that is evidence-based, simple and avoiding unnecessary expenses, must be developed.